Table 3.
Self-Reported Adherence and Electronic Monitoring for Oral Hypoglycemic Agents and Antidepressants and Clinical Outcomes at 12 Weeks (n = 180)
| Self-Reported Adherence
|
Electronic Monitoring Adherence
|
|||
|---|---|---|---|---|
| Unadjusted OR [95% CI] | Adjusted ORa [95% CI] | Unadjusted OR [95% CI] | Adjusted ORa [95% CI] | |
| Type 2 diabetes mellitus | ||||
|
| ||||
| Achieved A1C <7% | 1.41 [0.72–2.74] | 0.94 [0.33–2.66] | 2.49 [1.32–4.69] | 3.52 [1.07–11.57] |
|
| ||||
| Depression | ||||
|
| ||||
| Achieved remission (PHQ-9 <5) | 1.53 [0.79–2.94] | 0.71 [0.27–1.86] | 1.88 [1.03–3.46] | 0.76 [0.27–2.20] |
Adherence was operationalized as ≥80% adherence.
A1C indicates glycated hemoglobin; CI, confidence interval; OR, odds ratio; PHQ-9, 9-item Patient Health Questionnaire.
a
Adjusted for age, ethnicity, gender, marital status, educational attainment, functional status, frequency of medication administration, number of medications, number of medical conditions, cognitive status, intervention condition, and baseline clinical outcome.